Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

Timothy M. Uyeki(Centers for Disease Control and Prevention), Henry H. Bernstein(Cohen Children's Medical Center), John S. Bradley(University of California San Diego), Janet A. Englund(Seattle Children's Hospital), Thomas M. File(Northeast Ohio Medical University), Alicia M. Fry(Centers for Disease Control and Prevention), Stefan Gravenstein(Brown University), Frederick G. Hayden(University of Virginia Health System), Scott A. Harper(Centers for Disease Control and Prevention), Jon Mark Hirshon(University of Maryland, Baltimore), Michael G. Ison(Northwestern University), Bree Johnston(Dalhousie University), Shandra L. Knight(National Jewish Health), Allison McGeer(University of Toronto), Laura E. Riley(Massachusetts General Hospital), Cameron R. Wolfe(Duke Medical Center), Paul Alexander(Infectious Diseases Society of America), Andrew T. Pavia(University of Utah)
Clinical Infectious Diseases
October 5, 2018
Cited by 760Open Access
Full Text

Abstract

These clinical practice guidelines are an update of the guidelines published by the Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. This document addresses new information regarding diagnostic testing, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal influenza. It is intended for use by primary care clinicians, obstetricians, emergency medicine providers, hospitalists, laboratorians, and infectious disease specialists, as well as other clinicians managing patients with suspected or laboratory-confirmed influenza. The guidelines consider the care of children and adults, including special populations such as pregnant and postpartum women and immunocompromised patients.


Related Papers

No related papers found

Powered by citation graph analysis